Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127603631 | 12760363 | 1 | I | 20160909 | 20160919 | 20160919 | EXP | TW-MYLANLABS-2016M1039787 | MYLAN | CHEN KH, LIN SK, CHANG MC, HU WH.. ABSENCE OF CLOZAPINE-INDUCED AGRANULOCYTOSIS FOLLOWING LONG-TERM RECHALLENGE: REPORT OF ONE CASE.. TAIWANESE J PSYCHIATRY.. 1998;12 (1):83 | 0.00 | Y | 0.00000 | 20160919 | OT | TW | TW |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127603631 | 12760363 | 1 | PS | CLOZAPINE. | CLOZAPINE | 1 | 300 MG, UNK | Y | U | 75417 | 300 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127603631 | 12760363 | 1 | Schizophrenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127603631 | 12760363 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127603631 | 12760363 | Agranulocytosis | |
| 127603631 | 12760363 | Constipation | |
| 127603631 | 12760363 | Dry mouth | |
| 127603631 | 12760363 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |